Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs RC Callaghan, JK Cunningham, J Sykes, SJ Kish Drug and alcohol dependence 120 (1-3), 35-40, 2012 | 295 | 2012 |
Pharmaceutical development of AAV-based gene therapy products for the eye GA Rodrigues, E Shalaev, TK Karami, J Cunningham, NKH Slater, ... Pharmaceutical research 36 (2), 29, 2019 | 215 | 2019 |
Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine‐related hospital admissions JK Cunningham, LM Liu Addiction 98 (9), 1229-1237, 2003 | 184 | 2003 |
Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders RC Callaghan, JK Cunningham, G Sajeev, SJ Kish Movement Disorders 25 (14), 2333-2339, 2010 | 162 | 2010 |
Methamphetamine use and schizophrenia: a population-based cohort study in California RC Callaghan, JK Cunningham, P Allebeck, T Arenovich, G Sajeev, ... American Journal of Psychiatry 169 (4), 389-396, 2012 | 161 | 2012 |
Alcohol use among Native Americans compared to whites: Examining the veracity of the ‘Native American elevated alcohol consumption’belief JK Cunningham, TA Solomon, ML Muramoto Drug and Alcohol Dependence 160, 65-75, 2016 | 150 | 2016 |
Impacts of federal precursor chemical regulations on methamphetamine arrests JK Cunningham, LM Liu Addiction 100 (4), 479-488, 2005 | 123 | 2005 |
Topical drug delivery to the posterior segment of the eye: addressing the challenge of preclinical to clinical translation GA Rodrigues, D Lutz, J Shen, X Yuan, H Shen, J Cunningham, ... Pharmaceutical research 35 (12), 245, 2018 | 107 | 2018 |
The clinical picture of Hodgkin's disease JE Ultmann, JK Cunningham, A Gellhorn Cancer Research 26 (6_Part_1), 1047-1060, 1966 | 98 | 1966 |
Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease P Mauch, D Gorshein, J Cunningham, S Hellman Cancer Treat Rep 66 (4), 809-817, 1982 | 95 | 1982 |
All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study RC Callaghan, JK Cunningham, M Verdichevski, J Sykes, SR Jaffer, ... Drug and alcohol dependence 125 (3), 290-294, 2012 | 65 | 2012 |
Impact of US and Canadian precursor regulation on methamphetamine purity in the United States JK Cunningham, LM Liu, R Callaghan Addiction 104 (3), 441-453, 2009 | 64 | 2009 |
Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting JK Cunningham, LM Liu, M Muramoto Addiction 103 (7), 1174-1186, 2008 | 59 | 2008 |
Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease J Cunningham, P Mauch, DS Rosenthal, GP Canellos Cancer Treat Rep 66 (4), 1015-1022, 1982 | 47 | 1982 |
Development and evaluation of the See Me Smoke-Free multi-behavioral mHealth app for women smokers JS Gordon, J Armin, MD Hingle, P Giacobbi Jr, JK Cunningham, ... Translational behavioral medicine 7 (2), 172-184, 2017 | 44 | 2017 |
Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment JK Cunningham, LM Liu Social science & medicine 66 (7), 1463-1473, 2008 | 43 | 2008 |
Lessons learned in the development and evaluation of RxCoach™, an mHealth app to increase tobacco cessation medication adherence JS Gordon, JS Armin, JK Cunningham, ML Muramoto, SM Christiansen, ... Patient education and counseling 100 (4), 720-727, 2017 | 39 | 2017 |
Effects of the minimum legal drinking age on alcohol-related health service use in hospital settings in ontario: a regression–discontinuity approach RC Callaghan, M Sanches, JM Gatley, JK Cunningham American journal of public health 103 (12), 2284-2291, 2013 | 37 | 2013 |
US federal cocaine essential (‘precursor’) chemical regulation impacts on US cocaine availability: an intervention time–series analysis with temporal replication JK Cunningham, RC Callaghan, LM Liu Addiction 110 (5), 805-820, 2015 | 33 | 2015 |
Parents' evaluations of the effects of the 3M/House cochlear implant on children JK Cunningham Ear and Hearing 11 (5), 375-381, 1990 | 33 | 1990 |